Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 USD | -2.78% | +3.96% | +90.91% |
19/04 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
01/04 | Xilio Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
XILIO THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -2.78% | +3.96% | +90.91% | -67.08% | - | 39.86M |
Technical Rankings Surperformance
- Stock Market
- Equities
- XLO Stock
- Charts Xilio Therapeutics, Inc.
- Comparison Chart